Sun down on latest Indian US FDA import alert
Sun Pharma’s antibiotic facility import alert is the latest blow to the Indian drug industry but is unlikely to impact revenues or cause US shortages, the firm says.
Archives for March 13, 2014
EMA wants to make risk management for new drugs more transparent
As part of an effort to increase transparency, the EMA (European Medicines Agency) has published the first summary of a risk-management plan (RMP) of a newly authorised medicine.
breaking news - update 2
CRL to buy Argenta and Biofocus from Galapagos for €134m
Preclinical CRO Charles River Labs has announced plans to buy discovery services firms Argenta and BioFocus from Galapagos NV.
CMO future? Consolidation and strategic alliances, says Patheon/DSM Exec
In an exclusive interview, Patheon Executive Mike Lehmann talks DSM integration, further growth and how consolidation amongst CMOs may be driving strategic alliances with pharma.
Parexel joins cloud-based community of life science companies
Cloud-based community provider Exostar has selected Parexel as the latest CRO to become a member of its life science community, which aims to reduce the cost and burdens of collaborations between companies.
Australia risks losing leading pharma opium supplier status
Australia may lose its status as the leading supplier of pharma grade opium if it does not comply with Big Pharma requests and allow cultivation of the crop on the mainland.